|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] MR For Rare Disease (Clinical Scientific
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
11.27 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] MR For Rare Disease
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
12.16 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] RA Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
2³â¡è |
ä¿ë½Ã |
08.06 |
|
|
(ÁÖ)Å¥¶óƼ½º |
Å¥¶óƼ½º »ç¾÷°³¹ßÆÀ Á¤±ÔÁ÷ ä¿ë °ø°í
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
2³â¡è |
ä¿ë½Ã |
05.16 |
|
|
»ïÀÏÁ¦¾à(ÁÖ) |
¸¶ÄÉÆú»ºÎ ETC¸¶ÄÉÆà ´ã´ç ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
2³â¡è |
ä¿ë½Ã |
12.22 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] MR For Rare Disease
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
12.02 |
|
|
(ÁÖ)¾¾¾Ø¾¾ |
¿µ»óÀÇÇаú ÀÇ·á±â±â¿µ¾÷ÆÀÀå(¼¿ï°³²±Ù¹«)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
11.05 |
|
|
(ÁÖ)ºê·¹ÀÎÇãºê |
ÀÓ»ó½ÃÇè QA
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
03.15 |
|
|
(ÁÖ)ÇѸ²Å×Å©³î·ÎÁö |
ÀÇ·á¿ë ħ´ë ¿µ¾÷Á÷ ¸ðÁý(°æ·Â)
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
12.08 |
|
|
(ÁÖ)À¯¿µÁ¦¾à |
[°æ·Â] PVÆÀ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
05.26 |
05.17 |
|
|
ºê·¹ÀÎÇãºê |
¿Ü±¹°è ¼ö¼ú¿ë ÀÇ·á±â±â Product Manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
2³â¡è |
ä¿ë½Ã |
10.12 |
|
|
(ÁÖ)½ì¹ÙÀÌ¿ÀÅØ |
[µà¿À¶ô] ¾à±¹ ¹× º´ÀÇ¿ø ¿µ¾÷ °æ·Â(¼¿ï,¼öµµ±Ç)
¼¿ï ¼Ãʱ¸, °æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
08.21 |
|
|
Pharmax Ogilvy Healthworld |
CRA ¸ðÁý(´ë¸®°úÀå±Þ)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
09.20 |
|
|
À§´Ï´õ½ºÄÁ¼³Æà |
¿Ü±¹°è»ç ¸¶ÄÉÆà 2³âÀÌ»ó
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
2³â¡è |
ä¿ë½Ã |
10.10 |
|
|
(ÁÖ)Çѱ¹½´³ÚÁ¦¾à |
Çѱ¹½´³ÚÁ¦¾à ´ë°ü¾÷¹« ¹× ÀÎÇã°¡ ¾÷¹« °æ·ÂÀÚ ¸ðÁý
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
2³â¡è |
ä¿ë½Ã |
09.30 |
|